Bydureon and Staphylococcal infection - a phase IV clinical study of FDA data

Summary:

Staphylococcal infection is reported as a side effect among people who take Bydureon (exenatide synthetic), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Metformin, and have Hypotension.

The phase IV clinical study analyzes which people have Staphylococcal infection when taking Bydureon. It is created by eHealthMe based on reports of 24,229 people who have side effects when taking Bydureon from the FDA, and is updated regularly.

What is Bydureon?

Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 24,309 Bydureon users. Check the latest studies of Bydureon.

What is Staphylococcal infection?

Staphylococcal infection (an infection with staphylococcus bacteria) is found to be associated with 1,724 drugs and 1,898 conditions by eHealthMe. Check the latest studies of Staphylococcal infection.

On Jul, 13, 2026

24,229 people reported to have side effects when taking Bydureon.
Among them, 23 people (0.09%) have Staphylococcal infection.

Could Bydureon cause Staphylococcal infection?

Among these 23 people:

How long have people been on Bydureon when they have Staphylococcal infection? *

What is the gender of people who have Staphylococcal infection when taking Bydureon? *

female: 78.26 %
male: 21.74 %

What is the age of people who have Staphylococcal infection when taking Bydureon? *

What are other drugs people take besides Bydureon? *

What are other side effects people have besides Staphylococcal infection? *

Fatigue (feeling of tiredness): 6 people, 26.09%
Pain: 5 people, 21.74%
Abscess Limb (limb infection): 5 people, 21.74%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 17.39%
Nerve Injury: 4 people, 17.39%
Paronychia (infection in the tissues adjacent to a nail on a finger or toe): 4 people, 17.39%
Joint Pain: 4 people, 17.39%
Itching: 4 people, 17.39%
Scar: 4 people, 17.39%
Cellulitis Gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis)): 4 people, 17.39%

What are the existing conditions these people have? *

Weight Decreased: 4 people, 17.39%
Immunodeficiency Common Variable: 4 people, 17.39%
Hypotension (abnormally low blood pressure): 4 people, 17.39%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.35%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 4.35%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.35%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.35%
Immunodeficiency: 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%
High Blood Cholesterol: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Bydureon and have Staphylococcal infection?

- Check whether Staphylococcal infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bydureon:

Bydureon (24,309 reports)

Browse all side effects of Bydureon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Staphylococcal infection:

Staphylococcal infection (1,724 drugs)

Browse all the conditions that are associated with Staphylococcal infection:

Staphylococcal infection (1,898 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on exenatide synthetic (the active ingredients of Bydureon) and Bydureon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.